Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeoVax Labs Inc

1.12
+0.03002.75%
Post-market: 1.130.0100+0.89%16:17 EDT
Volume:273.73K
Turnover:304.16K
Market Cap:17.02M
PE:-0.23
High:1.14
Open:1.12
Low:1.09
Close:1.09
Loading ...

GeoVax Labs Inc. Conducted Annual Stockholders Meeting

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and Baxter International (BAX)

TIPRANKS
·
02 May

GeoVax Labs Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 May

GeoVax Labs Reports Q1 2025: Revenue Up to $1.6M, Net Loss Narrows to $5.4M

Reuters
·
02 May

GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update

NewMediaWire
·
02 May

GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting

NewMediaWire
·
30 Apr

GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater

NewMediaWire
·
25 Apr

GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress

NewMediaWire
·
25 Apr

GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025

NewMediaWire
·
23 Apr

GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations

NewMediaWire
·
22 Apr

GeoVax Labs Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Apr

GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital

TipRanks
·
16 Apr

GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum

NewMediaWire
·
16 Apr

Roth MKM Reaffirms Their Buy Rating on GeoVax Labs (GOVX)

TIPRANKS
·
16 Apr

Analysts Are Bullish on These Healthcare Stocks: GeoVax Labs (GOVX), Tango Therapeutics (TNGX)

TIPRANKS
·
16 Apr

Roth says BARDA stopping funding for GeoVax COVID trial similar to peers

TIPRANKS
·
16 Apr

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live
·
16 Apr

Crude Oil Moves Lower; Citigroup Posts Upbeat Results

Benzinga
·
16 Apr

GeoVax to Present Clinical Data at Upcoming April Industry Events

NewMediaWire
·
15 Apr

GeoVax Labs price target lowered to $8.50 from $15 at Alliance Global Partners

TIPRANKS
·
15 Apr